IDEX BIOMETRICS ASA (IDEX.OL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 1.5M 3M 4.5M FY23: 4.1M FY24: 841K FY23 FY24

Gross Profit Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Annual

-30M -20M -10M 0 10M 20M 30M FY23: -26.8M FY24: -21.9M FY23 FY24

Net Income Annual

-30M -20M -10M 0 10M 20M 30M FY23: -26.6M FY24: -14.4M FY23 FY24

Cost of Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Annual

-30M -20M -10M 0 10M 20M 30M FY23: -27M FY24: -17.5M FY23 FY24

Free Cash Flow Annual

-45M -30M -15M 0 15M 30M 45M FY22: -31.6M FY23: -27.2M FY22 FY23

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.